<i>TERT</i> Promoter Mutations in Familial and Sporadic Melanoma

Susanne Horn(German Cancer Research Center), Adina Figl(German Cancer Research Center), P. Sivaramakrishna Rachakonda(German Cancer Research Center), Christine Fischer(Heidelberg University), Antje Sucker(Essen University Hospital), Andreas Gast(German Cancer Research Center), Stephanie Kadel(German Cancer Research Center), Iris Moll(Essen University Hospital), Eduardo Nagore(Fundación Instituto Valenciano de Oncología), Kari Hemminki(German Cancer Research Center), Dirk Schadendorf(Essen University Hospital), Rajiv Kumar(German Cancer Research Center)
Science
January 24, 2013
Cited by 1,806

Abstract

Cutaneous melanoma occurs in both familial and sporadic forms. We investigated a melanoma-prone family through linkage analysis and high-throughput sequencing and identified a disease-segregating germline mutation in the promoter of the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic subunit of telomerase. The mutation creates a new binding motif for Ets transcription factors and ternary complex factors (TCFs) near the transcription start and, in reporter gene assays, caused up to twofold increase in transcription. We then screened the TERT promoter in sporadic melanoma and observed recurrent ultraviolet signature somatic mutations in 125 of 168 (74%) of human cell lines derived from metastatic melanomas, 45 of 53 corresponding metastatic tumor tissues (85%), and 25 of 77 (33%) primary melanomas. The majority of those mutations occurred at two positions in the TERT promoter and also generated binding motifs for Ets/TCF transcription factors.


Related Papers

No related papers found

Powered by citation graph analysis